Dermatology Times’ Post

Thoughts on this? >> Lilly's lebrikizumab, delayed at FDA, clears eczema in people with skin of color >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #competitivemarketing #pharma #pharmaceutical

Thoughts on this? >> #EADV24: Novo's semaglutide shows potential in chronic skin condition in obese patients >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #healthcare #pharmaceutical

Alexa B. Kimball, and colleagues review the current research on targeted therapies for hidradenitis suppurativa, including FDA-approved biologics and therapies in phase III and II trials. #hidradenitisSuppurativa #biologics #JAKinhibitors https://lnkd.in/g-SNJNhY

Check out the first part of my Pharmaceutical Executive video interview, with Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, when he discusses how is LEO Pharma positioning itself to capitalize on the unmet needs, patient centric initiatives, and more

At the #AAD2024, J&J touted strong long-term follow-up data from the first targeted oral peptide candidate in plaque psoriasis. The investigational JNJ-2113 could maintain (or even improve) levels of skin clearance through one-year. J&J is also running several Phase III studies for JNJ-2113, including the ICONIC-ADVANCE 2 trial, which will pit it against BMS's Sotyktu. #biotech #biopharma #psoriasis

Vertex’s pain drug succeeds in late-stage studies, marking major breakthrough in search for new, non-opioid medicines >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #productmarketing #pharma #pharmaceutical

Thoughts on this? >> Lilly's lebrikizumab, delayed at FDA, clears eczema in people with skin of color >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #pharma #healthcare #biotech

Thoughts on this? >> Are providers ready for biosimilars? >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #biotech #healthcare #pharmaceutical

Thoughts on this? >> Are providers ready for biosimilars? >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #healthcare #pharmaceutical #biotech

📆 Mark your calendar – Commercial Day Webinar   Join our executive team as we outline the key steps #Botanix Pharmaceuticals is taking to prepare to commercialize Sofdra™ for the prescription treatment of primary axillary hyperhidrosis (excessive underarm sweating).    This webinar is an opportunity for investors to gain valuable understanding of our proprietary product, market strategy, and launch plans following the expected approval in late June 2024.   SAVE THE DATE > Wednesday 8 May, 10.30am AEST | 8.30am AWST   Registration details will follow shortly.   $BOT #ASX #dermatology #pharmaceuticals #pharma #biotech #innovation #hyperhidrosis #launch